Clinical and laboratory findings of patients with SLE. Except for p values and where otherwise indicated, data are mean ± SD.
| Groups | A-LN | R-LN | NR-SLE | p* |
|---|---|---|---|---|
| SLEDAI-2K | 8.6 ± 5.3 | 0.7 ± 1.3 | 0.5 ± 0.0 | < 0.001 |
| rSLEDAI | 6.0 ± 2.9 | 0.0 ± 0.0 | ND | — |
| C3, mg/dl | 114.07 ± 54.40 | 134.87 ± 46.73 | ND | 0.117 |
| C4, mg/dl | 22.67 ± 16.25 | 28.00 ± 15.31 | ND | 0.196 |
| Anti-dsDNA, n (%) | 0.101 | |||
| Positive | 10/30 (33.3) | 4/30 (13.3) | ND | |
| Negative | 20/30 (66.7) | 26/30 (86.7) | ||
| Proteinuria, g/24 h | 1.97 ± 1.53 | 0.21 ± 0.15 | ND | < 0.001 |
| Serum creatinine, mg/dl | 1.04 ± 0.65 | 1.04 ± 0.29 | ND | 0.077 |
↵* p < 0.05. ND: not determined; A-LN: active lupus nephritis; R-LN: remission lupus nephritis; NR-SLE: nonrenal systemic lupus erythematosus; SLEDAI-2K: SLE Disease Activity Index 2000; rSLEDAI: renal SLEDAI.